Publications by authors named "Vicente Valero"

100Publications

Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients.

Eur J Radiol 2020 Sep 10;130:109170. Epub 2020 Jul 10.

Breast Imaging Department, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2020.109170DOI Listing
September 2020

Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study.

Cancer Prev Res (Phila) 2020 Sep 8;13(9):795-802. Epub 2020 Jun 8.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-20-0095DOI Listing
September 2020

Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations.

Breast J 2020 Aug 4;26(8):1572-1582. Epub 2020 Jun 4.

Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13922DOI Listing
August 2020

Impact of delayed neoadjuvant systemic chemotherapy on overall survival among breast cancer patients.

Oncologist 2020 May 20. Epub 2020 May 20.

Health Services Research Department, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0744DOI Listing
May 2020

An inflammatory imposter: Three cases of Mullerian carcinoma appearing as inflammatory breast cancer.

Breast J 2020 May 20;26(5):1022-1024. Epub 2020 Jan 20.

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13757DOI Listing
May 2020

Elevated serum levels of sialyl Lewis X (sLe) and inflammatory mediators in patients with breast cancer.

Breast Cancer Res Treat 2019 Aug 3;176(3):545-556. Epub 2019 May 3.

Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1220 Holcombe Blvd, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05258-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653624PMC
August 2019

Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1).

Breast Cancer Res Treat 2019 Jul 11;176(1):227-234. Epub 2019 Apr 11.

Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-05081-zDOI Listing
July 2019

A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β.

Invest New Drugs 2018 12 11;36(6):1103-1109. Epub 2018 Oct 11.

Department of Breast Medical Oncology, Dan L. Duncan Building (CPB5.3542), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-018-0672-z
Publisher Site
http://dx.doi.org/10.1007/s10637-018-0672-zDOI Listing
December 2018

Survival and Functional Status After Bridge-to-Transplant with a Left Ventricular Assist Device.

ASAIO J 2019 Sep/Oct;65(7):661-667

From the Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAT.0000000000000874DOI Listing
May 2020

Overall survival in older patients with cancer.

BMJ Support Palliat Care 2020 Mar 22;10(1):25-35. Epub 2018 Sep 22.

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjspcare-2018-001516DOI Listing
March 2020

Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy.

Int J Radiat Oncol Biol Phys 2018 11 19;102(3):568-577. Epub 2018 Jun 19.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.06.016DOI Listing
November 2018

Development of CNS metastases and survival in patients with inflammatory breast cancer.

Cancer 2018 06 26;124(11):2299-2305. Epub 2018 Mar 26.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31336DOI Listing
June 2018

Neurocognitive deficits in older patients with cancer.

J Geriatr Oncol 2018 09 9;9(5):482-487. Epub 2018 Mar 9.

Department of Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2018.02.010DOI Listing
September 2018

Factors associated with improved outcomes for metastatic inflammatory breast cancer patients.

Breast Cancer Res Treat 2018 Jun 19;169(3):615-623. Epub 2018 Feb 19.

Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4715-0DOI Listing
June 2018

A phase II study of tipifarnib and gemcitabine in metastatic breast cancer.

Invest New Drugs 2018 04 27;36(2):299-306. Epub 2018 Jan 27.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building, CPB5.3542, 1515 Holcombe Blvd., Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-018-0564-2
Publisher Site
http://dx.doi.org/10.1007/s10637-018-0564-2DOI Listing
April 2018

Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience.

Support Care Cancer 2018 May 2;26(5):1561-1568. Epub 2017 Dec 2.

Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-3962-7DOI Listing
May 2018

Optimal Selection of Breast Cancer Patients for Elimination of Surgery Following Neoadjuvant Systemic Therapy.

Ann Surg 2018 12;268(6):e61-e62

Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000002573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056325PMC
December 2018

Risk factors for falls in older patients with cancer.

BMJ Support Palliat Care 2018 Mar 31;8(1):34-37. Epub 2017 Aug 31.

Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjspcare-2017-001388DOI Listing
March 2018

Circulating Epithelial Cells in Intraductal Papillary Mucinous Neoplasms and Cystic Pancreatic Lesions.

Pancreas 2017 08;46(7):943-947

From the Departments of *Surgery, †Gastroenterology, and ‡Pathology, The Johns Hopkins Hospital, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000869DOI Listing
August 2017

Skin Necrosis After Ado-Trastuzumab Emtansine Extravasation.

J Oncol Pract 2017 08 5;13(8):555-556. Epub 2017 Jul 5.

Baylor College of Medicine; The University of Texas Health Science Center at Houston; and The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.020198DOI Listing
August 2017

The Role of Carboplatin in the Neoadjuvant Chemotherapy Treatment of Triple Negative Breast Cancer.

Oncol Rev 2017 Mar 17;11(1):324. Epub 2017 Mar 17.

Hematology/Oncology and Medical Director of Memorial Cancer Institute, Memorial Healthcare System , Hollywood, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/oncol.2017.324DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365000PMC
March 2017

Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.

Lancet Oncol 2017 04;18(4):e228-e232

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30192-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140765PMC
April 2017

Identification of frequent somatic mutations in inflammatory breast cancer.

Breast Cancer Res Treat 2017 Jun 27;163(2):263-272. Epub 2017 Feb 27.

Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4165-0DOI Listing
June 2017

Molecular Profiling Using Breast Cancer Subtype to Plan for Breast Reconstruction.

Plast Reconstr Surg 2017 Mar;139(3):586e-596e

Houston, Texas From the Departments of Plastic and Reconstructive Surgery, Biostatistics, Pathology, Breast Medical Oncology, Surgical Oncology, and Radiation Oncology, The University of Texas M. D. Anderson Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PRS.0000000000003050DOI Listing
March 2017

Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.

J Clin Oncol 2017 Apr 30;35(10):1049-1060. Epub 2017 Jan 30.

W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Maheshwari Ramineni, Kelly Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy Moulder, and Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston; Andrew Walls, Uniformed Services University of the Health Sciences, San Antonio, TX; Mei Liu, The General Hospital of People's Liberation Army, Beijing, China; Alex Bousamra, Allegheny General Hospital, Pittsburgh, PA; Bruno Sinn, Charite-Universitatsmedizin, Berlin, Germany; and Lajos Pusztai and Christos Hatzis, Yale University School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.1010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455352PMC
April 2017

The Impact of Paravertebral Block Analgesia on Breast Cancer Survival After Surgery.

Reg Anesth Pain Med 2016 Nov/Dec;41(6):696-703

From the *Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center; †Anesthesiology and Surgical Oncology Research Group; and Departments of ‡Breast Medical Oncology, §Breast Surgical Oncology, and ∥Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AAP.0000000000000479DOI Listing
March 2017

Predictors of left ventricular systolic function recovery in the setting of sinus tachycardia in patients with cancer.

Echocardiography 2017 Jan 21;34(1):29-36. Epub 2016 Oct 21.

Department of Cardiology, Division of Medicine, MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/echo.13372DOI Listing
January 2017

HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials.

J Clin Oncol 2016 10;34(29):3518-3528

Michael F. Press, Denice D. Tsao-Wei, Yanling Ma, Ivonne Villalobos, and Anaamika Campeau, University of Southern California Norris Comprehensive Cancer Center; Dennis J. Slamon, Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA; Nicholas Robert, Virginia Cancer Specialists/US Oncology Research Network, Fairfax, VA; Vicente Valero, The University of Texas MD Anderson Cancer Center, Houston, TX; Guido Sauter and Martina Mirlacher, University of Hamburg, Hamburg; Wolfgang Eiermann, Frauenklinik vom Roten Kreuz, Munich, Germany; Marc Buyse, Hélène Fourmanoir, and Emmanuel Quinaux, International Drug Development Institute, Louvain-la-Neuve, Belgium; Tadeusz Pienkowski, Postgraduate Medical Education Center, Warsaw, Poland; John Crown, Irish Cooperative Onoclogy Research Group, St Vincent's University Hospital, Dublin, Ireland; Miguel Martin, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain; John R. Mackey, University of Alberta; Mary-Ann Lindsay, Cancer International Research Group/Translational Research in Oncology, Edmonton, Alberta, Canada; and Valerie Bee, Cancer International Research Group/Translational Research in Oncology, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.6693DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074347PMC
October 2016

T-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers That Received Prior Therapy With Trastuzumab and Pertuzumab.

J Clin Oncol 2016 10;34(29):3511-3517

Hannah Dzimitrowicz, Annette Hood, Osama Abdelghany, Christos Hatzis, and Lajos Pusztai, Yale University School of Medicine, New Haven, CT; Michael Berger and Craig Vargo, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH; and Akshara Singareeka Raghavendra, Debu Tripathy, Vicente Valero, and Rashmi Murthy, MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.3624DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075965PMC
October 2016

Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy.

Ann Surg 2017 05;265(5):978-986

*Departments of Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA †Departments of Surgery, University of Verona, Verona, Italy ‡Departments of Surgery, Mayo Clinic, Jacksonville, FL §Departments of Surgery, University of Calgary, Calgary, Alberta ¶Departments of Surgery, Indiana University School of Medicine, Indianapolis, IN ||Departments of Surgery, University of Tennessee Health Science Center, Memphis, TN **Departments of Surgery, Jefferson Medical College, Philadelphia, PA ††Departments of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH ‡‡Departments of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA §§Departments of Surgery, University of Alabama School of Medicine, Birmingham, AL ¶¶Departments of Surgery, University of Glasgow, Glasgow, Scotland ||||Departments of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA ***Departments of Surgery, Baylor College of Medicine, Houston, TX †††Departments of Surgery, University of Florida College of Medicine, Gainesville, FL ‡‡‡Departments of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA §§§Departments of Surgery, Yale School of Medicine, New Haven, CT ¶¶¶Departments of Surgery, Johns Hopkins School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000001796DOI Listing
May 2017

Disparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast Cancer.

Int J Radiat Oncol Biol Phys 2016 07 10;95(4):1218-25. Epub 2016 Mar 10.

University of Texas, MD Anderson Cancer Center, Houston, Texas; MD Anderson Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.02.065DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051526PMC
July 2016

Lipofilling of the Breast Does Not Increase the Risk of Recurrence of Breast Cancer: A Matched Controlled Study.

Plast Reconstr Surg 2016 Feb;137(2):385-93

Houston, Texas; and Ann Arbor, Mich. From the Departments of Plastic and Reconstructive Surgery, Surgical Oncology, Radiation Oncology, and Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center; and the Department of Breast Radiation Oncology, University of Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.prs.0000475741.32563.50DOI Listing
February 2016

Epidemiological risk factors associated with inflammatory breast cancer subtypes.

Cancer Causes Control 2016 Mar 21;27(3):359-66. Epub 2016 Jan 21.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1155 Pressler St., Unit 1360, P.O. Box 301439, Houston, TX, 77230, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-015-0712-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778706PMC
March 2016

Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.

Ann Surg 2016 Dec;264(6):1073-1081

*Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD†Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD‡Department of Medical Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD§Department of Radiation Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD¶Department of Gastroenterology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD||Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000001600DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936958PMC
December 2016

Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation.

Ann Surg 2016 Aug;264(2):344-52

*Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania†Department of Surgery, Mayo Clinic, Jacksonville, Florida‡Department of Surgery, University of Calgary, Calgary, Canada§Department of Surgery, University of Verona, Verona, Italy¶Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana||Department of Surgery, University of Tennessee Health Science Center, Memphis, Tennessee**Department of Surgery, Jefferson Medical College, Philadelphia, Pennsylvania††Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio‡‡Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts§§Department of Surgery, University of Alabama School of Medicine, Birmingham, Alabama¶¶Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts||||Department of Surgery, Baylor College of Medicine, Houston, Texas***Department of Surgery, University of Florida College of Medicine, Gainesville, Florida†††Department of Surgery, Yale School of Medicine, New Haven, Connecticut‡‡‡Department of Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000001537DOI Listing
August 2016

Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients.

Ann Surg Oncol 2016 May 17;23(5):1515-21. Epub 2015 Dec 17.

Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-5020-3DOI Listing
May 2016

High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast Cancer.

Oncologist 2016 Jan 9;21(1):21-7. Epub 2015 Dec 9.

Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709200PMC
January 2016

MELD-XI Score Predicts Early Mortality in Patients After Heart Transplantation.

Ann Thorac Surg 2015 Nov 19;100(5):1737-43. Epub 2015 Sep 19.

Division of Cardiac Surgery, The Johns Hopkins Hospital, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2015.07.026DOI Listing
November 2015

Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast Cancer.

J Natl Cancer Inst 2015 Nov 14;107(11). Epub 2015 Sep 14.

Departments of Surgical Oncology (CSH, MK, BAL, HMK, SD, AEA, AL), Surgical Pathology (SK), Breast Medical Oncology (VV, NTU), and Biostatistics (LY, SX), The University of Texas MD Anderson Cancer Center, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849361PMC
November 2015

Recurrence and survival among breast cancer patients achieving a pathological complete response to neoadjuvant chemotherapy.

Breast Cancer Res Treat 2015 Sep 14;153(2):417-23. Epub 2015 Aug 14.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1444, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10549-015-3533
Web Search
http://link.springer.com/10.1007/s10549-015-3533-x
Publisher Site
http://dx.doi.org/10.1007/s10549-015-3533-xDOI Listing
September 2015

Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical Management.

Ann Surg 2016 Jan;263(1):153-61

*Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD †Department of Pathology ‡Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD §Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD ¶Department of Gastroenterology and Hepatology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/SLA.0000000000001156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662640PMC
January 2016

Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer.

Clin Breast Cancer 2015 Oct 24;15(5):325-31. Epub 2015 Mar 24.

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2015.03.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568133PMC
October 2015

A novel risk scoring system reliably predicts readmission after pancreatectomy.

J Am Coll Surg 2015 Apr 8;220(4):701-13. Epub 2015 Jan 8.

Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2014.12.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452114PMC
April 2015